You have 9 free searches left this month | for more free features.

Drug-Related Side Effects and Adverse Reactions

Showing 9951 - 9975 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acupuncture, Taste Disorders, Dysgeusia Trial in Essen, Mannheim (Hypoglossal acupuncture, Sham acupuncture, Dietary

Recruiting
  • Acupuncture
  • +4 more
  • Hypoglossal acupuncture
  • +2 more
  • Essen, NRW, Germany
  • +2 more
Dec 5, 2022

Remimazolam Sedation for Nerve Blocks

Not yet recruiting
  • Procedural Anxiety
  • Procedural Pain
  • Remimazolam 20 MG [Byfavo]
  • Salt Lake City, Utah
    University of Utah
Jun 7, 2022

NSCLC Trial in United States (ALT-803, Nivolumab)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • ALT-803
  • Nivolumab
  • Weston, Florida
  • +3 more
Dec 5, 2022

Parkinson Disease Trial in Farmington Hills, Leeuwarden (Lu AF28996)

Recruiting
  • Parkinson Disease
  • Lu AF28996
  • Farmington Hills, Michigan
  • +1 more
Dec 5, 2022

Post-operative Delirium, Cognitive Dysfunction, Electroencephalography Trial in Istanbul (Bupivacaine-fentanyl, Saline)

Recruiting
  • Post-operative Delirium
  • +2 more
  • Istanbul, Fatih, Turkey
    Bezmialem Vakif University Hospital
Jan 15, 2023

Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)

Not yet recruiting
  • Recurrent High Grade Glioma
  • +4 more
  • (no location specified)
Jan 24, 2023

Aging Trial in Irvine (Zolpidem)

Recruiting
  • Aging
  • Irvine, California
    Sleep and Cognition Lab
May 18, 2021

Type 2 Diabetes Trial in Exeter (Sitagliptin - DPP4i, Canagliflozin - SGLT2i, Pioglitazone - TZD)

Completed
  • Type 2 Diabetes
  • Sitagliptin - DPP4i
  • +2 more
  • Exeter, United Kingdom
    Exeter Clinical Research Facility
Mar 30, 2021

Healthy Volunteers Trial in Miami (CTP-543)

Completed
  • Healthy Volunteers
  • Miami, Florida
    Clinical Pharmacology of Miami
Jul 14, 2021

Carcinoma, Squamous Cell, Head Neck Cancer Trial in Lexington (Cisplatin, XRT)

Recruiting
  • Carcinoma, Squamous Cell
  • Head and Neck Cancer
  • Lexington, Kentucky
    University of Kentucky
Nov 17, 2021

BRAF V600E Unresectable or Metastatic Melanoma, BRAF V600E Metastatic NSCLC, Melanoma Trial in Guangzhou (Encorafenib)

Completed
  • BRAF V600E Unresectable or Metastatic Melanoma
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jun 9, 2022

Atopic Dermatitis Trial in Worldwide (MEDI3506, Placebo)

Completed
  • Atopic Dermatitis
  • Birmingham, Alabama
  • +41 more
Oct 11, 2022

Magnesium Sulfate, Postoperative Pain, Opioid Use Trial in São Paulo (Remifentanil group, Magnesium sulfate group)

Recruiting
  • Magnesium Sulfate
  • +2 more
  • Remifentanil group
  • Magnesium sulfate group
  • São Paulo, Brazil
    Hospital das Clínicas - Faculdade de Medicina da Universidade de
Mar 2, 2022

Kidney Cancer Trial in Houston (Pazopanib, Temsirolimus, Quality of Life Assessment)

Completed
  • Kidney Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 24, 2021

Critical Lower Limb Ischemia, Peripheral Artery Disease Trial in Singapore (SELUTION Sirolimus DCB)

Active, not recruiting
  • Critical Lower Limb Ischemia
  • Peripheral Artery Disease
  • SELUTION Sirolimus DCB
  • Singapore, Singapore
    Singapore General Hospital
May 24, 2022

Peripheral Arterial Disease Trial in Germany, New Zealand, Switzerland (Temporary Spur Stent System)

Active, not recruiting
  • Peripheral Arterial Disease
  • Temporary Spur Stent System
  • Arnsberg, Germany
  • +5 more
May 3, 2022

Cirrhosis Trial in Washington, San Juan (Defined Green Tea Catechin Extract, Laboratory Biomarker Analysis, Pharmacological

Active, not recruiting
  • Cirrhosis
  • Defined Green Tea Catechin Extract
  • +3 more
  • Washington, District of Columbia
  • +1 more
Jan 24, 2023

Immune Thrombocytopenia Trial (Herombopag)

Not yet recruiting
  • Immune Thrombocytopenia
  • (no location specified)
Jan 13, 2023

Treatment Compliance Trial in Karachi (to evaluate the safety and efficacy of Ansa for the treatment of UTi and control of Ecoli

Recruiting
  • Treatment Compliance
  • to evaluate the safety and efficacy of Ansa for the treatment of UTi and control of Ecoli infection
  • Karachi, Sindg, Pakistan
  • +1 more
Oct 6, 2022

Rendu Osler Disease, Telangiectasia, Hereditary Hemorrhagic Trial (Bevacizumab)

Completed
  • Rendu Osler Disease
  • Telangiectasia, Hereditary Hemorrhagic
  • (no location specified)
Oct 14, 2021

Palmoplantar Pustulosis (PPP) Trial in Japan (Risankizumab, Placebo)

Active, not recruiting
  • Palmoplantar Pustulosis (PPP)
  • Ichinomiya-shi, Aichi, Japan
  • +38 more
Mar 1, 2022

An Observational Study on Sarilumab-exposed Pregnancies

Recruiting
  • Rheumatoid Arthritis -Exposure During Pregnancy
  • Sarilumab SAR153191 (REGN88)
  • New York, New York
  • +1 more
Jul 5, 2022

Obesity, Adolescent, Eating, Healthy Trial in Bilbao (Values alignment wise intervention, Educational traditional intervention)

Recruiting
  • Obesity, Adolescent
  • Eating, Healthy
  • Values alignment wise intervention
  • Educational traditional intervention
  • Bilbao, Vizcaya, Spain
    University of Deusto
May 9, 2023

Radiation Esophagitis Trial in United States (Sucralfate, Usual Care, One consent)

Recruiting
  • Radiation Esophagitis
  • Basking Ridge, New Jersey
  • +6 more
Dec 13, 2022

Anesthesia Trial (Propofol, Sevoflurane, Ephedrine)

Not yet recruiting
  • Anesthesia
  • (no location specified)
Jul 4, 2023